TNF-α and its receptors, i.e., soluble tumor necrosis factor receptors (sTNFR) 1 and 2 capable of regulating numerous physiological processes in CNS, have been reported to aggravate the Aβ and tau pathologies in AD patients (58). The gene discussed is MAPT; the disease is Alzheimer disease.